CID 215035

1-piperazinepropanamide, 4-(8-chloro-10,11-dihydrodibenzo(b,f)thiepin-10-yl)-, (z)-2-butenedioate (1:1)

Structural Information

Molecular Formula
C21H24ClN3OS
SMILES
C1CN(CCN1CCC(=O)N)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)Cl
InChI
InChI=1S/C21H24ClN3OS/c22-16-5-6-20-17(14-16)18(13-15-3-1-2-4-19(15)27-20)25-11-9-24(10-12-25)8-7-21(23)26/h1-6,14,18H,7-13H2,(H2,23,26)
InChIKey
OGAAPGIBCNGJKO-UHFFFAOYSA-N
Compound name
3-[4-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

401.13287 Da
Monoisotopic Mass

3.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 402.140146 192.6
[M+Na]+ 424.122088 198.0
[M-H]- 400.125594 197.2
[M+NH4]+ 419.166693 203.1
[M+K]+ 440.096028 195.2
[M+H-H2O]+ 384.130130 183.9
[M+HCOO]- 446.131071 196.5
[M+CH3COO]- 460.146721 199.6
[M+Na-2H]- 422.107536 192.3
[M]+ 401.13232142 188.6
[M]- 401.13341858 188.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.